CEO understanding we objectively be here address have for Thanks after will has for of action the company strategy Stepping going of experience for the of current a the I vision allowed me our implement to good business having prior years, in very of changes commercial Joe. immediately success. up us the number the and that diagnose situation role set My challenges to take at forward. and TransEnterix been and a a into part what can a
views X, to these Turning would present to Slide follows. I as like
First, commercial as market what and know capabilities its well as and the we about Senhance landscape. the
product over do have our we learned plans dynamics. the what do last we to execute on market about our commercialization initiatives. be need our years to what few successful and strategy, offering, these and to still global Second, third, And
on is execute turning that Slide system with converting strategy on benefits to company exclusively a through robotics. or Starting surgeons platform. robotic only to market to our the this of surgery naturally that maintain are unique designed with our to are approaches strategy combination and viable experience product in offering target we laparoscopies, highest either enabling and strategy on economically allows XX. to laparoscopy, development. experience other a the level, and laparoscopic focused comfortable what To us hospitals, know, not that the we enhance At to procedures This technologies for the is of laparoscopic today surgical provide robotic was the
instruments advancing large X and comparable to standards. This maintaining so they mm cost surgery doing convert is reusable. incision no increasing to the minimally to are in of Our based laparoscopy. market. market at is X the of way. robotic are the and and a that open knowledge on procedures number laparoscopy other mm proposition, and procedure Senhance up approaching the is and allows size are us this a assistance in value without path robotic fully best our They expand diameter of invasive to These clear This the company help economics will and to
they Our surgeon provides for utilize learning same very by a the short the laparoscopy. This system curve. using an opportunity movements is hand controlled in
can to we offers Our to are that and feedback improve bring provides image surgeon system in advanced their life an No architecture these Haptic important other a they that company's also instrumentation the laparoscopy control can and surgical quality robotics experience, surgeon in through ergonomic experience experiencing stability be surgery. which achieved of improvement the patient with only care. solutions, robotic and and accustomed laparoscopic and
of address care form that enhance differentiated settings. We a many procedures some that technology order the the coming In for technologies realized, in experts, industry will this decade across have for have be robotic will of the array believe be call where to to can our we with we surgical we continue and of vision adopted laparoscopy. assistance. also digital broad experience take surgery needs to surgeons, majority to Together to the have
capability demands believe surgery. we participated focus address laparoscopy laparoscopies to Therefore on the enhance expansion in us Senhance's market and uniquely of that position continuing robotic of the to and our
to that that With behind We clinical global other digital believe navigate start robotics realize laparoscopy and develop a potential. how safely also with our to well on we we to know and surgery strong platform clearances it a reproducibly is no challenging this can regulatory have experience, head and company the perform as landscape. our as us, meaningful regulatory focused
times, the Turning robotic to instruments current primarily by limited has converting growing been nicely, and larger This the robotic. market relatively procedure and use The is to high traditional has Slide limited XX, has than large open and to yet market been laparoscopy. costs, surgeries procedure is while robotic requirement been on laparoscopic primarily penetration sizable it focused penetration. longer has
uniquely Senhance these all believe challenges. We that addresses
ability robotic assistant economically current number robotic As by a serve. expand procedures we of a have result, capturing laparoscopic of the the offerings procedures share materially to that cannot
to you can strong thousands the Turning of on optic a performed XX, see thus Slide far we XXXX. with in left that procedures have
specialties, more the the This demonstrating on that variety XX and a that in XXXX right of across traditional urology. to you first can combined. to procedures general surgical deep procedures digital experience months In than see including gynecology performed laparoscopic about And laparoscopy. clinical we wide is surgical and shows the potential across specialties XXXX fact, has Senhance of convert Senhance multiple applicability surgery, broad XXXX XX%
demonstrate topic customers we the several sites these procedure system know, engaging strong conducting at they the hospital Senhance high high what is the foundational of a proposition customer is surgeons know that the diversity clearly conclude refer proposition. With sites and customers to Senhance also our of so are These and do we achieve for as representing volume XX, with surgical numerous value several there Slide We to that seven within validated Turning many specialties. demonstrate surgeons value can to by economically. monthly specialties by surgery rates. that because
curve. platform, Importantly, this, know performing up allows year. From a that ramp Senhance the customers almost and of speaks to that we which began are learning our Senhance of implementing half volume of customers procedure short we with capable the surgery ease training, of program this these our quickly to versatility
our XX% out customer these would I under active also -- base. that installed seven point represent sites XX% of
has performance we will learnings these I action of going the represent which very our sites, are percentage that commercial of While I with they the forward. plans address modest fact pleased our talk a impacted our installed when about adoption base and
growth market sales to XX, and the unique not more Slide our proposition we that surgery seemingly question we position our have would revenues. what on to evidence Senhance and strong to fair like learned. is to converted is have I commercial well value performing Turning significant opportunity, into hospitals, discuss why this a it ask, Based in increasing
Here is my assessment.
we sales high prematurely. ramp, Turning typical amount value release build Senhance on pre-commercial our our that strong delivering force feedback, significant controlling Senhance demonstrate a capital of number phase to without awareness of of market users includes to the a the quickly proposition. rapid a a the to moved emphasis improvements, a use cost to a sales small system make Slide focused and resources XX, we gain on limited on Based launch first
in percent the with was for market system time. for So that we learned prime lessons these paid not who ready customers a hundred
implement we we standpoint had from of that been the software ready Many required rather early these and of to able a have dynamics market in prime to challenges which minor created to is address than system challenges now we these a curve Some time. have performance updates for negative learning react that upfront.
the instruments Second, barrier launching was to the particular, acceptance. without lack of a a early presented energy limitation major of a full complement to adoption. advanced In system
We year. our have advanced launching addressed this energy this instrument early by
hospitals provide the our on early systems wasn’t to of market-leading choice, to we spoke of the of until most third-party to compatibility that market. systems with allow were this year it vision vision but ability also We their use able
of also to of be a a While number The created sales. occasionally articulating significant barrier done devices. lack has articulation without procedures can
we adding after As in a in to have and I clearance. articulation the U.S. regulatory will discuss in pathway XXXX shortly, Europe
a growth Senhance our result Third, potential focus base the offer. a a has what building that demonstrate meaningful on not as to is a of prioritizing user realizing over base portion our full helps sales of us value proposition, strong installed of
across sites experiences follow. purchase, successful installed to an that sales these satisfied of of tell are base the enthusiastic with While publications consistently our efforts. we to bolster leverage support story others surgical and base, majority currently Without our selling lacked their can't compels their to user a team them
point is final progress hampered we sales and had thus to have financial The growth that on many primarily materialized, the our The expected in strong this by our made not although fronts significantly of sales we in has half our XXXX, stock these topic this concerns. make I'll price. optics in on year condition back that was due the far, effectiveness of
As you concerns. a and heard we undertaking from address steps Paul these of are to number remarks, Joe’s
to Now clinical still work and do have we need have expansion. these development, to to that lessons shareholders. about, of what validation, put There what speaking emphasis are that where we will be to areas we learned, I'm create established and are three discuss value and we going drive I for portfolio results to market
market area the XX, development. first is Slide of emphasis to Turning
are customers in for more increase near-term One create that the in visibility is our to marketplace of the most important the having to the focus with areas Senhance. proof the points of success us of
number focus expanding and into increasing the utilization consistent system additional emerging surgeons using into foundational the the the by to sites evolving we existing our specialties. system, of increasing sites of First, need on
need U.S., programs Second, new we in sites at the of implement focus Europe regions, and each to strategic Senhance Japan. our
who increase positive the with speak Third, we program. surgeons our about of speaker their experiences formalize need and to will number Senhance
Lastly, the channels we on of will expanded multiple and technology drive clinical through the use events. speaker programs and peer-to-peer data
area the of second clinical XX, Slide emphasis to development Turning the is of evidence.
of While real of sites, our we in to propositions this we support to evidence the it at ability have critical is reality field, Senhance foundational seen expand our continue the world that value become especially belief. many
that other to ability is One of reusable our and our therefore platforms. robotic instruments value lower laparoscopy, propositions costs by significantly key driven similar the procedure maintain to strategy are
data, in users work have months to this continue coming this with and would collecting of We to current expect while evidence expand to be procedure we the costs. our low published additional the users
have seen existing efficiency, implement learning also OR while case particularly maintaining customers of Senhance terms times in and programs We curve.
to amount data published forward. to expect the of We topic continue this expand going around
as Laparoscopic fatigue, in career. surgeons' both the on of impact as performance, the concerned surgeons can and physical are cognitive in of deeply the quality and of longevity well life terms about have the it surgical
outcomes know size already demonstrates of X reducing insufficient the in that with X mm that are we mm use our a to Finally, improve we strong that the Senhance will instruments outcomes. clinical data robotically build improves enabled position and clinical clinical instruments on
and sales increase with we are in future. these near these well of facing extremely grow today hospitals deliberately the evidence collecting will themes by on align to ability All the our that challenges fronts,
eye continue our leading differentiated followed technologies. offering we Today, camera as to to platform, a those control, to XX, with mm discuss indications X last tracking expanding instrument and the have of must should haptic offering few. who familiar the Turning technologies, We procedure today you have Slide innovate of a company. instruments be market area by to emphasis robotic feedback, name to and such
instruments in once launch of in towards other limited we is our to geographies. approvals X and Europe expect The regulatory our and complete, instruments Europe, in ongoing work these articulating subsequently key launch mm
CE use bariatrics the as our We for Senhance. expand regulatory and of labeling from pediatric Mark FDA also have to well ongoing ranging gathering data programs to indications obtaining general in as expand a surgery
for we strong. Finally, a these is about digitizing surgery for enthusiasm discussing initiatives year, very the surgeon have our in been technologies and
align to data of in coming additional for XXXX, and the timeline units have in leading this demonstrating in been technology submit on U.S. gathering launch should the FDA timed regulatory market this technologies our to these significant clinical the expect nicely which very pre-production efforts. with us should of with utilization This mid to progress be months. We position and continue a
up expect the to XX, discuss I should in to see from Slide quickly wrap before progress XXXX. me On let us shift you
not significant know, terms what sites being for made Senhance well system the In of is that of good at consistently. us surgeons has although surgery was XXXX. routinely company, we used visible The in are it much of XXXX where progress we positioned multiple outside performing
program, them see We evidence value that addition patients has the allowing with be in robotics to continue to unique are market hospitals more Senhance economic responsible a can to bring starting a to complimentary proposition, approach. to robotics
to commercial and that that ensure learned our the make market have refine the to to we pieces We reinvesting approach in need our have place infrastructure in prudent. put we
develop activities, and As features, a on and will areas important indications intelligence Senhance scene cognition market as result, system new be in of economic evidence, clinical supporting the to our for augmented focus the expanding our adding use. expanding and XXXX such key
resources targeted these in resources favor the we goals. we from as smaller, more infrastructure noted, of to a our achieving away commercial remainder While continue sales commercial systems of sell on and have focus will Joe shifted our force
what you So by from the end of us expect should see XXXX? to
build XX, leadership to to category. the XXXX out Moving in laparoscopy we significant we our Slide as expect digital continue to make in progress
convert support We Senhance. do will to customers and sites surgeons To be strategic need hundred prioritize foundational revenue a multiple annually criteria over with emerging new parallel, near-term the adding objective sites, specialties. cases are on plus those that rate recognition. that working run sites of will our In we to or into expand the number we using will perform specific this,
cases. sites, enhance We array impactful key broad advocates events. cascade By at growing existing number peer-to-peer messages intend we number adding through to and our to a surgeon the of new of cases expect to help sites clinical of double increase the
that each the we front, evidence generate will key value expect propositions. we clinical On our meaningful of that supports
we Intelligence In Scene cognition terms launched by module the expect portfolio have to mid-XXXX. of expansion, and Augmented
achieve surgery to expect also in expect indications that match we what EU and indication in the a general U.S. the pediatric we addition, bariatric EU. we in to will In have and get
XXXX, the have In in we foundational that place expand infrastructure. put believe to will of pieces to we prudently summary, by the support commercial reinvesting end our
all the In want built ourselves success. thank you have we join do I taking time progress hope you us to have in we what position conveyed made I foundation closing, to commercial the for need we to have to of we for to today. in XXXX. strong The XXXX and
of While us I'm are opportunity has enthusiastic And to position on of we the to as raise the we in system for about market. front unique need of our the vision. to the work mindful execute have and have the capital in do the Senhance necessary us
I I team we that As this journey. communication goals. Transenterix assure go public committed increase with our and will progress the the forward, our to along members you share of along are our we of achieving intend cadence other to
Thank you for for joining us again Transenterix. your of support and
